Cargando…
P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431166/ http://dx.doi.org/10.1097/01.HS9.0000970384.26808.c7 |
_version_ | 1785091136738557952 |
---|---|
author | Manier, Salomon Lesokhin, Alexander Mohty, Mohamad Niesvizky, Ruben Maisel, Christopher Arnulf, Bertrand Larson, Sarah M. Nina Varshavsky-Yanovsky, Asya Leleu, Xavier Karlin, Lionel Vesole, David H. Bahlis, Nizar J Fernandez de Larrea, Carlos Raje, Noopur Leip, Eric Sullivan, Sharon T. Elmeliegy, Mohamed Viqueira, Andrea Nooka, Ajay |
author_facet | Manier, Salomon Lesokhin, Alexander Mohty, Mohamad Niesvizky, Ruben Maisel, Christopher Arnulf, Bertrand Larson, Sarah M. Nina Varshavsky-Yanovsky, Asya Leleu, Xavier Karlin, Lionel Vesole, David H. Bahlis, Nizar J Fernandez de Larrea, Carlos Raje, Noopur Leip, Eric Sullivan, Sharon T. Elmeliegy, Mohamed Viqueira, Andrea Nooka, Ajay |
author_sort | Manier, Salomon |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104311662023-08-17 P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES Manier, Salomon Lesokhin, Alexander Mohty, Mohamad Niesvizky, Ruben Maisel, Christopher Arnulf, Bertrand Larson, Sarah M. Nina Varshavsky-Yanovsky, Asya Leleu, Xavier Karlin, Lionel Vesole, David H. Bahlis, Nizar J Fernandez de Larrea, Carlos Raje, Noopur Leip, Eric Sullivan, Sharon T. Elmeliegy, Mohamed Viqueira, Andrea Nooka, Ajay Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431166/ http://dx.doi.org/10.1097/01.HS9.0000970384.26808.c7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Manier, Salomon Lesokhin, Alexander Mohty, Mohamad Niesvizky, Ruben Maisel, Christopher Arnulf, Bertrand Larson, Sarah M. Nina Varshavsky-Yanovsky, Asya Leleu, Xavier Karlin, Lionel Vesole, David H. Bahlis, Nizar J Fernandez de Larrea, Carlos Raje, Noopur Leip, Eric Sullivan, Sharon T. Elmeliegy, Mohamed Viqueira, Andrea Nooka, Ajay P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
title | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
title_full | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
title_fullStr | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
title_full_unstemmed | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
title_short | P870: EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN (BCMA)-DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES |
title_sort | p870: efficacy and safety of elranatamab in patients with relapsed/refractory multiple myeloma and prior b-cell maturation antigen (bcma)-directed therapies: a pooled analysis from magnetismm studies |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431166/ http://dx.doi.org/10.1097/01.HS9.0000970384.26808.c7 |
work_keys_str_mv | AT maniersalomon p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT lesokhinalexander p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT mohtymohamad p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT niesvizkyruben p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT maiselchristopher p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT arnulfbertrand p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT larsonsarahm p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT ninavarshavskyyanovskyasya p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT leleuxavier p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT karlinlionel p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT vesoledavidh p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT bahlisnizarj p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT fernandezdelarreacarlos p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT rajenoopur p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT leiperic p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT sullivansharont p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT elmeliegymohamed p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT viqueiraandrea p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies AT nookaajay p870efficacyandsafetyofelranatamabinpatientswithrelapsedrefractorymultiplemyelomaandpriorbcellmaturationantigenbcmadirectedtherapiesapooledanalysisfrommagnetismmstudies |